Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT03345355
Other study ID # LOCAL/2016/AL-01
Secondary ID
Status Terminated
Phase
First received
Last updated
Start date November 13, 2018
Est. completion date December 31, 2019

Study information

Verified date August 2021
Source Centre Hospitalier Universitaire de Nimes
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The investigators hypothesize that the T1 Dixon post-Gadolinium and T2 Dixon sequences will show good diagnostic performances for active sacroiliitis compared to the reference test (Short tau inversion recovery) and clinical-biological criteria, which will allow a better diagnosis of active sacroiliitis


Recruitment information / eligibility

Status Terminated
Enrollment 5
Est. completion date December 31, 2019
Est. primary completion date December 31, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - The patient must have given their free and informed consent and signed the consent form - The patient must be a member or beneficiary of a health insurance plan - The patient is at least 18 years old - The patient has a clinically diagnosed axial spondyloarthritis (axSpA) (ASAS or AMOR classification) - Patient has an active axSpA (BASDAI>4) Exclusion Criteria: - The subject is participating in another study, or is in a period of exclusion determined by a previous study - The subject refuses to sign the consent - It is impossible to give the subject informed information - The patient is under safeguard of justice or state guardianship - The patient is pregnant or breastfeeding - The patient has a contra-indication

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Imaging
Coronal oblique T1, Coronal oblique and axial STIR, Coronal oblique T1 Dixon, Coronal oblique and Axial T2 Dixon and T1 Dixon post Gadolinium

Locations

Country Name City State
France CHU Lapeyronie Montpellier
France CHU Nimes Nîmes

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Nimes

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Diagnostic performance of T1 Dixon post-Gadolinium and T2 Dixon for active sacroiliitis, according to subchondral edema status compared to ASAS criteria incorporating Short tau inversion recovery and clinic-biological elements Time 0
Secondary Diagnosis of enthesitis from T1 Gadolinium Dixon sequence vs ASAS criteria Yes/no Time 0
Secondary Diagnosis of synovitis from T2 Dixon and T1 Gadolinium Dixon sequences vs ASAS criteria Yes/no Time 0
Secondary Diagnosis of chronic sacroiliite (erosion or chondral scler osis, or fatty spinal replacement) by T1 Dixon pre-Gadolinium Yes/No Time 0
Secondary Diagnosis of chronic sacroiliite (erosion or chondral sclerosis, or fatty spinal replacement) by conventional sequences Yes/no Time 0
See also
  Status Clinical Trial Phase
Completed NCT03564743 - Description of Spondylarthritis and Validation of ASAS Criteria in West Indian Patients Seen in Consultation of Rheumatology.
Completed NCT01219257 - Longitudinal ULtrasonographic Study of Patients With Spondylarthritis Starting Biological Therapy
Recruiting NCT05433168 - Study Evaluating the Effectiveness of Shiatsu on Fatigue in Patients With Axial Spondyloarthritis N/A
Terminated NCT03232580 - 99mTc-rhAnnexin V-128 in Diagnosis of Spondyloarthritis Phase 2
Recruiting NCT05039216 - Biobank for Inflammatory Chronic Diseases and Osteoporosis
Completed NCT04483648 - Cervical Stabilization Exercises in Patients With Spondyloarthritis N/A
Recruiting NCT04602091 - Observational Study in Patients Treated With JAK Inhibitors for Inflammatory Rheumatism (MAJIK)
Not yet recruiting NCT04077957 - Treat-to-target Strategy in Ankylosing Spondylitis Using Etanercept and Conventional Synthetic DMARDs Phase 4
Recruiting NCT05290363 - The Role of IL-23 in Chronic Inflammatory Disease: Exploring the Cellular and Molecular Targets of IL-23 Signaling in Peripheral and Axial Spondyloarthritis N/A
Not yet recruiting NCT05006690 - Telerehabilitation, Face-to-Face and Home-Based Spinal Stabilization Exercise Training in Patients With Spondyloarthritis N/A
Completed NCT02998398 - Evaluation of the Switch From the Original Infliximab to Its Biosimilar in Daily Practice at Cochin Hospital
Completed NCT02148640 - The NOR-SWITCH Study Phase 4
Completed NCT01174186 - Intestinal Inflammation in Ankylosing Spondylitis and the Effects of Adalimumab on Mucosal Healing Phase 4
Recruiting NCT04499001 - Effect of Pharmaceutical Consultations Just Before Rheumatology Consultations on Improving Knowledge and Skills for Patients With Inflammatory Arthritis With Subcutaneous Biologic DMARDs
Completed NCT03253796 - Golimumab (MK-8259 / SCH900259) Treatment Withdrawal in Participants With Non-radiographic Axial Spondyloarthritis (GO-BACK) (MK-8259-038) Phase 4
Active, not recruiting NCT04169373 - A Study to Evaluate Efficacy and Safety of Upadacitinib in Adults With Axial Spondyloarthritis Phase 3
Recruiting NCT04292067 - Characterisation of Intestinal Microbiota of Patients With Spondyloarthritis or Rheumatoid Arthritis
Completed NCT04946539 - Value of Ultrasonographic Enthesitis Assessment in Spondyloarthritis
Recruiting NCT03983473 - Identification of Fecal Microbiota Biomarkers of Spondyloarthritis in Patients Suffering From Crohn's Disease. N/A
Completed NCT04360785 - Effect of Two Methotrexate in Sync With the First Adalimumab to Prevent the Immunisation Anti Ada in Spondyloarthritis N/A